의료기기 이야기

Introduction This document aims to clarify important terms and concepts that are outlined in Section 2 of Chapter VII of Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). Establishing a common understanding of these terms and concepts is necessary for the effective and harmonised implementation of the vigilance requireme..

Introduction and scope The introduction of the Unique Device Identification (UDI) system referred to in Article 27 of Regulation (EU) 2017/745 on medical devices (MDR) aims to ensure an adequate level of identification and traceability with respect to medical devices. Basic UDI-DIs, UDI-DIs and UDIPIs shall be assigned (in compliance with the rules of the designated issuing entities) by manufac..

BackgroundThe Medical Device Coordination Group (MDCG) has issued an update to the European vigilance guidance MDCG 2023-3. The document now covers devices regulated under the IVDR. As Emergo by UL reported last year, the initial version of MDCG 2023-3 explicitly excluded IVDs from its scope. Guidance on vigilance reporting for IVDsThe guidance now includes IVD-specific examples of incidents, se..

Introduction This document aims to clarify important terms and concepts that are outlined in Section 2 of Chapter VII of Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2017/746 on in vitro diagnostic medical devices (IVDR). Establishing a common understanding of these terms and concepts is necessary for the effective and harmonised implementation of the vigilance requireme..

Draft requirements for post-market surveillance (PMS) of medical devices in the U.K. align closely with European regulations, but not entirely. Below, Emergo by UL continues our analysis of the proposed legislation. As noted in a previous Regulatory Update, a draft post-market surveillance statutory instrument (PMS SI) was laid in the U.K. Parliament (October 21) to introduce new PMS and vigilan..

Returning from a long holiday and need to catch up on EU medical device and IVD regulatory developments? Read our update on European regulatory news over the last few months. Amending legislation published to extend the transition of legacy IVDs and roll out EUDAMEDRegulation 2024/1860 was officially released to extend the transition time for legacy IVDs, roll out EUDAMED, and require data on di..

The aim of this Device Specific Vigilance Guidance (DSVG) is to harmonise vigilance reporting and provide guidance for manufacturers of Specific Devices. It provides further clarification for vigilance reporting of Specific Devices to the relevant Competent Authority and should be read in conjunction with the requirements of Regulation (EU) 2017/745 on medical devices (MDR) and Regulation (EU) 2..

Emergo by UL에서 EU MDR 관련 웨비나 예정 일자: 2023년 09월 26일 오전 9시~10시 (CDT, 한국시간 저녁 11시~12시) 주제: EU MDR PMS including PMCF and Vigilance EU MDR PMS Including PMCF and Vigilance | Emergo by UL EU MDR PMS Including PMCF and Vigilance In this complimentary webinar, our Emergo by UL subject matter expert will outline the latest insights about EU MDR PMS, including PMCF and vigilance. www.emergobyul.com